| Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species M Guilliams, CA Dutertre, CL Scott, N McGovern, D Sichien, S Chakarov, ... Immunity 45 (3), 669-684, 2016 | 810 | 2016 |
| Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity H Husebye, Ø Halaas, H Stenmark, G Tunheim, Ø Sandanger, B Bogen, ... The EMBO journal 25 (4), 683-692, 2006 | 583 | 2006 |
| Primary antitumor immune response mediated by CD4+ T cells A Corthay, DK Skovseth, KU Lundin, E Røsjø, H Omholt, PO Hofgaard, ... Immunity 22 (3), 371-383, 2005 | 556 | 2005 |
| The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors M Djerbi, V Screpanti, AI Catrina, B Bogen, P Biberfeld, A Grandien The Journal of experimental medicine 190 (7), 1025-1032, 1999 | 527 | 1999 |
| Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer OAW Haabeth, KB Lorvik, C Hammarström, IM Donaldson, G Haraldsen, ... Nature communications 2 (1), 240, 2011 | 340 | 2011 |
| MHC class II—Restricted presentation of intracellular antigen S Weiss, B Bogen Cell 64 (4), 767-776, 1991 | 325 | 1991 |
| B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. S Weiss, B Bogen Proceedings of the National Academy of Sciences 86 (1), 282-286, 1989 | 293 | 1989 |
| How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? OAW Haabeth, AA Tveita, M Fauskanger, F Schjesvold, KB Lorvik, ... Frontiers in immunology 5, 174, 2014 | 236 | 2014 |
| Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type K Crozat, S Tamoutounour, TP Vu Manh, E Fossum, H Luche, L Ardouin, ... The Journal of Immunology 187 (9), 4411-4415, 2011 | 236 | 2011 |
| Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules B Bogen, B Malissen, W Haas European journal of immunology 16 (11), 1373-1378, 1986 | 226 | 1986 |
| Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma B Bogen European journal of immunology 26 (11), 2671-2679, 1996 | 212 | 1996 |
| Broad and largely concordant molecular changes characterize tolerogenic and immunogenic dendritic cell maturation in thymus and periphery L Ardouin, H Luche, R Chelbi, S Carpentier, A Shawket, FM Sanchis, ... Immunity 45 (2), 305-318, 2016 | 182 | 2016 |
| Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. GF Lauritzsen, S Weiss, Z Dembic, B Bogen Proceedings of the National Academy of Sciences 91 (12), 5700-5704, 1994 | 160 | 1994 |
| Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells A Os, S Bürgler, AP Ribes, A Funderud, D Wang, KM Thompson, ... Cell reports 4 (3), 566-577, 2013 | 133 | 2013 |
| Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte … S Balan, V Ollion, N Colletti, R Chelbi, F Montanana-Sanchis, H Liu, ... The Journal of Immunology 193 (4), 1622-1635, 2014 | 127 | 2014 |
| Vaccine molecules targeting Xcr1 on cross‐presenting DCs induce protective CD8+ T‐cell responses against influenza virus E Fossum, G Grødeland, D Terhorst, AA Tveita, E Vikse, S Mjaaland, ... European journal of immunology 45 (2), 624-635, 2015 | 120 | 2015 |
| Clonal deletion of specific thymocytes by an immunoglobulin idiotype. B Bogen, Z Dembic, S Weiss The EMBO journal 12 (1), 357-363, 1993 | 120 | 1993 |
| Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response KB Lorvik, C Hammarström, M Fauskanger, OAW Haabeth, M Zangani, ... Cancer research 76 (23), 6864-6876, 2016 | 112 | 2016 |
| Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target KW Schjetne, KM Thompson, N Nilsen, TH Flo, B Fleckenstein, JG Iversen, ... The Journal of Immunology 171 (1), 32-36, 2003 | 112 | 2003 |
| Delivery of antigen to CD40 induces protective immune responses against tumors KW Schjetne, AB Fredriksen, B Bogen The Journal of Immunology 178 (7), 4169-4176, 2007 | 108 | 2007 |
